Buy blood pressure medication online — ARBs, ACE inhibitors, beta-blockers, calcium-channel blockers, diuretics, alpha-blockers, central agents, nitrates and specialty pulmonary-hypertension therapy. Hypertension is the leading modifiable cause of stroke, ischaemic heart disease, heart failure, chronic kidney disease, and dementia. The 2018 ESC/ESH, 2017 ACC/AHA, and 2024 AHA hypertension guidelines centre systolic BP <130 mmHg as the primary target for most patients with established cardiovascular disease, diabetes, or CKD — each 10 mmHg systolic drop reduces major cardiovascular events by ~20% and stroke by ~27% across primary and secondary prevention populations. Choice of agent depends on age, ethnicity, comorbidity, target-organ damage, pregnancy status, and tolerability.Angiotensin-receptor blockers (ARBs) — first-line in younger patients, diabetics, post-MI, heart failure with reduced ejection fraction, and CKD with proteinuria. Telma (telmisartan), Valent (valsartan), Cozartan (losartan), Olmin and Olmeheal (olmesartan), and Irovel (irbesartan) cover the five most prescribed ARB molecules. ARB+HCTZ fixed-dose combinations — Telma H, Valzaar H, Losatec H, Cosart H, Cozartan H — are step-up therapy when monotherapy fails to reach target after 4–6 weeks. ARBs cause no cough (unlike ACE inhibitors) and minimal angio-oedema risk.ACE inhibitors — equivalent first-line option to ARBs, with stronger evidence in heart failure and post-MI. Cardace and Ramisave (ramipril) carry the largest secondary-prevention dataset (HOPE trial). Enapril (enalapril) and Hypernil (lisinopril) are the long-acting once-daily alternatives. Switch to an ARB if dry cough develops (5–15% of patients) or if the patient has a history of ACE-inhibitor angio-oedema.Beta-blockers — first-line when hypertension coexists with angina, post-MI, atrial fibrillation rate-control, or heart failure with reduced ejection fraction. Atenheal (atenolol) and Beloc (metoprolol) are the standard cardio-selective choices. Topme and Topme XL deliver metoprolol succinate (the heart-failure-licensed ER form). Nebilong (nebivolol) adds nitric-oxide-mediated vasodilation — preferred for elderly hypertension and erectile dysfunction concerns. Carvego (carvedilol) and Lobet (labetalol) offer combined alpha+beta blockade for resistant hypertension and pregnancy hypertension respectively. Provanol (propranolol) covers migraine prophylaxis and essential tremor.Calcium-channel blockers (CCBs) — first-line in older patients, Black African-Caribbean ethnicity, isolated systolic hypertension, and Raynaud’s phenomenon. Dihydropyridine CCBs Amlode (amlodipine) and Cardipin Retard (nifedipine retard) are the vascular-selective workhorses. Non-dihydropyridines Dilvas (diltiazem) and Tachyra (verapamil) lower heart rate in addition to BP — useful for AF rate-control and supraventricular tachycardia, but never combine with a beta-blocker (heart-block risk).Diuretics — thiazides such as Hydrocl (hydrochlorothiazide) are second- or third-line add-ons in step-up therapy. Loop diuretics are reserved for hypertension complicated by heart failure or CKD stage 4–5. Indapamide and chlortalidone are the long-acting thiazide-likes preferred by recent guidelines for cardiovascular outcomes (ALLHAT, HYVET).Alpha-blockers and central agents — reserved for resistant hypertension or specific comorbidities. Prazopill XL (prazosin XL) covers phaeochromocytoma, PTSD nightmares, and BPH-with-hypertension. Clodict (clonidine) is a centrally-acting alpha-2 agonist for resistant hypertension and ADHD — never stop abruptly (rebound hypertensive crisis).Nitrates — for stable angina prophylaxis and acute angina rescue. Sorbitrate (isosorbide dinitrate) is sublingual rescue plus oral prophylaxis. Monit (isosorbide mononitrate) is once-daily prophylaxis with asymmetric dosing to preserve nitrate-free interval and avoid tolerance.Specialty: pulmonary hypertension and chronic heart failure. Ambrican (ambrisentan) is a selective endothelin-A receptor antagonist for pulmonary arterial hypertension (PAH). Rioci 1 (riociguat) is a soluble guanylate-cyclase stimulator for PAH and CTEPH. Ivabrad (ivabradine) lowers heart rate via funny-channel inhibition without affecting BP — for chronic heart failure (LVEF <35%) on maximally tolerated beta-blocker. Lonitab (minoxidil) is a potent arterial vasodilator for resistant hypertension that has failed three-drug therapy. Minoxytop is the same molecule at low dose used off-label for androgenetic alopecia.How to choose. Stage 1 hypertension (140–159 / 90–99) in a patient under 55 → ARB or ACE inhibitor monotherapy. Patient over 55 or Black African-Caribbean → CCB monotherapy. Stage 2 hypertension (≥160/100) → start two-drug combination directly (ARB+CCB or ARB+thiazide). Resistant hypertension on three drugs → add spironolactone, then alpha-blocker, then central agent. Pregnancy → labetalol, methyldopa, or nifedipine retard only (ACE inhibitors and ARBs absolutely contraindicated). Diabetic with proteinuria → ARB or ACE inhibitor first regardless of age.All MedsBase blood-pressure medications are FDA-approved generics manufactured by WHO-GMP certified producers. Worldwide shipping. Loyalty points apply on every order.
2026 buyer’s guide: See our shortlist Best Blood Pressure Medications 2026 for ranked picks, comparison table, dosing notes and decision shortcut.